Astellas Pharma GmbH
Astellas Pharma GmbH
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma | Penile Squamous Cell Carcinoma (PSCC) | Recruiting | Phase 2 | 2026-06-22 | NCT07110038 |